Paclitaxel inhibits N-acetyltransferase activity and gene expression in human stomach tumor cells (SC-M1)

Research Communications in Molecular Pathology and Pharmacology

Volumn 115-116, Issue , 2004, Pages 21-38

  Hsia, Te Chun ^a   Yang, Jen Hung ^b   Lin, Hui Ju ^a,c   Yu, Chun Shu ^d   Yu, Fu Shun ^d   Chung, Jing Gung ^d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; DNA adduct; Human stomach cancer cell line (SC M1); N acetyltransferase; Paclitaxel

Indexed keywords

ACYLTRANSFERASE; DNA; MESSENGER RNA; PACLITAXEL; ANTINEOPLASTIC AGENT; ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450; N (2 FLUORENYL)ACETAMIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DNA ADDUCT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH TUMOR; BIOSYNTHESIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; KINETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

2-ACETYLAMINOFLUORENE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; KINETICS; PACLITAXEL; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 34447272216     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., Huang, Y. (1993). Taxol induces intemucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7, 563-568.
2. Blum, M., Grant, D. M., McBride, W., Heim, M., Myere, U. A. (1990). Huma arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 9, 193-203.
3. Boissy, R. J., Watson, M. A., Umbach, D. M., Deakin, M., Elder, J., Strange, R. C.(2000). A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int. J. Cancer. 87, 507-511.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Cartwright, R. A., Glasham, R. W., Rogers, H. J., Ahmed, R. A., Barham-Hall, D., Higgens, E., Kahn, M. A. (1982). Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet. 2, 842-846.
6. Cleland, W. W. (1967). The statistical analysis of enzyme kinetic data. Adv. Enzymol. 29, 1-32.
7. Dipple, A., Michejda, C. J., Weisburger, E. K. (1985). Metabolism of chemical carcinogens. Pharmacol. Ther. 27, 265-296.
8. Dipple, A. (1996). DNA adducts of chemical carcinogens. Carcinogenesis (Lond.) 16, 437-441
9. Donebower, R. C., Rowinsky, E. K. (1994). Paclitaxel. Prin. & Prac. Oncol. 10, 1-16
10. Donadio, M.,Manzin, E., Berruti, A., Bottini, A., Gorzegno, G.,Danese, S., DeFabiani, E., Surobba, M. G., Lorusso, V., Castiglione, F., Moro, G., Bertetto, O., Bumma, C., Dogliotti, L. (2001). Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-prereated metastatic breast cancer patients. A multicenter phase II trial. Cancer Chemother Pharmacol. 47, 391-396.
11. Donaldson, K. L.,Goolsby, G. L., Wahl, A. F. (1994). Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57, 847-855.
12. Einisto, P., Watanabe, M., Ishidate, M., Nohmi, T. Mutagenecity of 30 chemicals in S.typhimurium possessing different nitroreductase or O-acetyltransferase activities. (1991) Mutation Res. 259, 95-102.
13. Ebisawa ,T., Deguchi, T. (1991) Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferase. Biochem. Biophys. Res. Comun. 177, 1252-1257.
14. Ferrari, A. C., Chachoua, A., Singh, H., Rosenthal, M., Taneja, S., Bednar, M., Mandeli, J., Muggia, F. (2001). A pgase I/II study of weekly palcitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma. Cancer. 91, 2039-2045.
15. Ham, H. J., Shen, K. L., Liu, C. A., Ho, L. I., Yang, L. S., Yueh, K. C. (1998). Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1. J. Pathol. 184, 291-296.
16. Ilett, K. F.,David, B. M., Detchon, P., Castledon, W. M., Kwa, R. (1987). Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469.
17. Jiang, S. V., Shyu, R. V., Chen, H. Y., Lee, M. M., Wu, K. L., Yeh, M. Y. (1996). In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid. Oncology. 53, 334-340.
18. Kadlubar, F. f. in: K. Hemminki, A., Dipple, D. E. G. Shuker, F. F. Kadlubar, D. Segerback, and H. Bartsch (eds.). DNA adducts, Identification and Biological Significance, IARC Scientific Publication. No. 125, pp 199-216 (1994). Lyon: IARC.
19. Katoh, T., Boissy, R., Nagata, N., Kitagawa, K., Kuroda, Y., Itoh, H., Kawanoto, T. Bell, D. A.,(2000). Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int. J. Cancer. 85, 46-49.
20. Lang, N. P.,Chu, D. Z. J., Hunter, C. F., Kendall, D. C., Flammang, T. F., Kadlubar, F. F. (1986). Role of aromatic amines acetyltransferase in human colorectal cancer. Arch Surg. 121, 1259-1261.
21. Levy, G. N., Chung, J. G., Weber, W. W. (1994) 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis. 15, 353-357.
22. Levy, G. N., Weber, W. W. (1989). 2-Aminofluorene-DNA adduct formation in acetylator congenic mouse lines. Carcinogenesis. 10, 705-709.
23. Lieu, C. H.,Chang, Y. N., Lai, Y. K. (1997). Dual Cytotoxic Mechanisms of Submicromolar Taxol on Human Leukemia HL-60 Cells. Biochem Pharmacol 53, 1587-1596.
24. Lopes, N. M., Adams, E. G., Pitts, T. W., Bhuyan, B. K. (1993). Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol. 32, 235-242.
25. Lower, G. M. (1982) Concepts in causality: chemically induced human urinary bladder cancer. Cancer 49, 1056-1066.
26. Manfredi, J. J., Parness, J., Howitz, S. B. (1982). Taxol binds to cellular microtubules. Taxol binds to cellular microtubules. J. Cell Biol. 94, 688-696.
27. Miller, E. C., Miller J. A. (1981). Searches for the ultimate chemical carcinogens and their reaction with cellular macromolecules. Cancer 47, 2327-2345.
28. Milas, I., Hunter, N. R., Kurdoglu, B., Mason, K. A., Meyn, R. E., Stephens, L. C., Peters, L. J. (1995). Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol. 35, 297-303.
29. Neumann, H. G. (1986). The role of DNA damage in chemical carcinogenesis of aromatic amines. J. Cancer Res. Clin. Oncol. 112, 100-106.
30. Ponte, P., Ng, S. Y., Engel, J., Gunning, P., Kedes, L. (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12, 1687-1696.
31. Safran, H.,Wanebo, H. J., Hesketh, P. J., Akerman, P., Ianitti, D., Cioffi, W., DiPetrillo, T., Wolf, B., Koness, J., McAnaw, R., Moore, T., Chen, M. H., Radie-Keane, K. (2000) Paclitaxel and concurrent radiation for gastric cancer. Int. J. Radiat Oncol. Biol. Phys. 46, 889-894.
32. Schiff, P. B., Horwitz, S. B. (1980). Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Nat Acad Sci USA 77, 1561-1565.
33. Tomita, M., Kurata, H., Aoki, Y., Tanaka, K., Kazama, J. J. (2001). Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer. Anticancer Drugs. 12, 485-487.
34. Umemura,T.,Tokumo, K., Sima, H., Gebhardt, R., Poirier, M. C., Williams, G. M. (1993). Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Letts. 73, 1-10.
35. Walpole, A. L.,Williams, M. H. C., Roberts, D. C. (1954). Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br. J. Indust. Med. 11, 105-109.
36. Wani, M. C., Taylor, H. L., Wall, M. E. (1971). Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia. J. Am. Chem. Soc. 93, 2325-2342.
37. Weber, W. W., Hein, D. W. (1985). N-acetylation pharmacogenetics. Pharmacol. Rev. 37, 25-79.
38. Yang, C. C., Chung J. G. (2001). Sulindac inhibited gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in human bladder tumor cells (T24). Urological Research. 29: 406-411.
39. Zubay, G. L., Parson, W. W., Vance, D. E. Principles of Biochemistry. pp147. (1995). Wm. C. Brown Publishers.